What product is “Mylan Institutional LLC dexamethasone sodium phosphate”?
“Dexamethasone sodium phosphate” is a corticosteroid drug used for its anti-inflammatory and immune-suppressing effects. When listed as “Mylan Institutional LLC dexamethasone sodium phosphate,” the name typically points to a specific manufacturer/labeler on the product packaging or regulatory listing for that drug.
Who makes it and what does “Mylan Institutional LLC” mean?
“Mylan Institutional LLC” is a legal entity associated with Mylan’s branded/generic drug distribution and institutional supply. On many drug labels and listings, the applicant/labeler name can differ from the parent company brand name.
Is this a brand, a generic, or an approved drug listing?
“Dexamethasone sodium phosphate” is an established active ingredient. The “Mylan Institutional LLC” wording generally indicates the company responsible for the specific marketed product of that ingredient, rather than the ingredient being unique or proprietary.
Where does DrugPatentWatch.com fit in?
DrugPatentWatch.com tracks patent and exclusivity information for drugs, which can be useful if you’re trying to determine whether a particular dexamethasone sodium phosphate product is covered by active patents or when exclusivity/patent barriers may end. If you share the exact dosage form strength (for example, injection, concentration, and package size) and whether you mean a specific National Drug Code (NDC), I can point you to the most relevant patent/exclusivity entry on DrugPatentWatch.com.
What details do you need to identify the exact product?
To nail down the correct listing (and any patent/exclusivity implications), the key missing details are usually:
- Dosage form (e.g., injection vs ophthalmic)
- Strength (e.g., mg/mL or mg per mL)
- Route (IV/IM, etc.)
- NDC or product code
- Whether you mean a specific labeler/manufacturer on a pharmacy listing
If you paste the NDC or the exact line from the label/listing (including strength and dosage form), I can help interpret what it refers to and, where applicable, connect it to patent/exclusivity coverage.
Sources
No sources were provided with your question, and no specific product identifiers (NDC/strength/dosage form) were included to look up a precise patent or regulatory record. If you share those details, I can provide targeted sourcing, including from DrugPatentWatch.com where relevant.